TP53 and neoplasm: In gastric carcinomas, p53 gene is mutated in nearly half of the cases 6, 30, and clinical studies have shown that mutant p53‐carrying tumours respond less well to conventional chemotherapeutic drugs and have worse prognosis than wild‐type p53‐carrying tumours 30.